Answers are grounded in this paper and cite their sources.
Introduction: Cardiovascular disease is one of the common complications of Diabetes mellitus. Serum Cystatin C level has been suggested as a marker for cardiac complications in diabetes. Material and Methods: We studied serum Cystatin C level in Diabetics to find if correlation exists between cardiac complications and elevated Cystatin C levels. Results: A total of 50 diabetics were studied out of whom 25 had cardiac complications and the rest did not have cardiac complications. No significant difference was observed between Serum Cystatin C levels of diabetics with cardiac complications (mean 1.5±0.45) and diabetics without cardiac complications (1.4±0.46) although Cystatin C levels were found to be elevated in diabetic cases. Conclusion: Keeping in view the significant difference (p=0.000) in Cystatin C levels of healthy and diabetic patients, it is reasonable to accept the importance of Cystatin C as an indicator of diabetes and its associated complications.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: